See also this year's filing and all EDGAR filings for this company.
PDF Report 0001505512_2020_Regulus_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001505512, Regulus Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 40,407,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 266,000 |
| 2 | PropertyPlantAndEquipmentNet | 921,000 |
| 3 | remainder_Assets | 487,000 |
| 4 | LiabilitiesCurrent | 21,598,000 |
| 5 | LiabilitiesNoncurrent | 468,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,870,849 |
| 9 | ResearchAndDevelopmentExpense | -45,649,653 |
| 10 | remainder_Expenses | 1,941,152 |
| 11 | remainder_Revenues | 5,170,047 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 42,081,000 |
| 1 | Liabilities | 22,066,000 |
| 2 | Expenses | -33,837,652 |
| 3 | Revenues | 5,170,047 |
| 4 | StockholdersEquity | 20,015,000 |
| 5 | NetIncome | 39,007,699 |
| 6 | ComprehensiveNetIncome | 39,007,699 |
| 7 | BaseVar | 51,577,350 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.58 |
| 9 | EconomicCapitalRatio | 3.41 |
Edgar->Model Mapping
Feature Distribution
Change over Time
